General MedicationsINJECTIONGeneric

BACTOCILL

OXACILLIN SODIUM

Standard Dose

EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview BACTOCILL is listed in Drugs@FDA under application 061334 (ANDA).

Marketing status: Discontinued Active ingredient OXACILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 1982-03-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview BACTOCILL is listed in Drugs@FDA under application 061334 (ANDA). Marketing status: Discontinued Active ingredient OXACILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 1982-03-26 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.